Eurepa V1/0.2 Tablet10's dressing reduces diabetic complications
Description
reduces diabetic complications
Safety Advice: Avoid in severe liver/kidney disease
About: Nutritional supplement with folate
Safety Advice: Do not discontinue without consulting doctor
About: Contains Glimepiride 0
Eurepa V1/0.2 Tablet10's dressing reduces diabetic complicationsAbout: Eurepa V1 0. 2 Tablet is a combination of Repaglinide and Voglibose, used for type2 diabetes. Usage Instructions Take before meals as directed by your doctor. Benefits Controls blood sugar, especially after meals. How it Works Repaglinide increases insulin release; Voglibose delays carbohydrate absorption. Side Effects May cause nausea, vomiting, or hypoglycemia. Safety Advice Monitor blood sugar, avoid skipping meals, and consult your doctor
Exchange/Return Notes
- We offer a 30-day return/exchange service after receiving.
- Final sale items are not eligible for returns or exchanges.
- To process your return/exchange, please contact us at [email protected]
- Please click here for more details>>> Return & Exchange Policy
























